GRI GRI Bio, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$1.96
· of 52w range
· above low
· to high
$1.3652w low
$64.1252w high
Market Cap (MRQ)
$4M
P/E
-0.1
EPS
$-121.80
your badges
52W Range
$1–$64
Analyst Rating
BUY
Price Target
$18
P/E
-0.1
ROE
-256.3%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
GRI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.96
Market Cap (MRQ)
$4M
P/E
-0.1
EPS
$-121.80
ROE
-256.3%
52W Range
$1–$64
GRI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Jan. 26, 2026 | 1-for-28 | Reverse |
| Feb. 24, 2025 | 1-for-17 | Reverse |
| June 18, 2024 | 1-for-13 | Reverse |
| Jan. 30, 2024 | 1-for-7 | Reverse |
| April 24, 2023 | 1-for-30 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2020-12-31 → 2021-12-31
EPS$-121.802020-12-31 → 2025-12-31
Free Cash Flow$-10M2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | GRI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.15Y avg ≈-39196.9 | ≈-39196.9 | · | · | |
| P/B (MRQ) | 0.45Y avg ≈80790.9 | ≈80790.9 | 0.4 | Fair value | |
| Price / FCF | -0.35Y avg ≈-56879.8 | ≈-56879.8 | · | · | |
| Price / Cash Flow | -0.35Y avg ≈-50590.3 | ≈-50590.3 | · | · | |
| Price / Tangible Book | 0.55Y avg ≈495.6 | ≈495.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | GRI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -166.0%5Y avg ≈-289.7% | ≈-289.7% | -68.1% | Weak | |
| ROE | -256.3%5Y avg ≈-245.8% | ≈-245.8% | -285.9% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | GRI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 10.35Y avg ≈2.7 | ≈2.7 | 3.2 | Strong liquidity | |
| Quick Ratio | 3.15Y avg ≈2.1 | ≈2.1 | 1.9 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-70.2%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-0.91 | $-1.21 | 24.6% |
| March 31, 2026 | May 13, 2026 | $-1.61 | $-0.91 | -76.1% |
| Dec. 31, 2025 | $-116.61 | $-29.55 | -294.6% | |
| Sept. 30, 2025 | $-35.84 | $-26.30 | -36.3% | |
| June 30, 2025 | $-36.68 | $-37.05 | 0.99% | |
| March 31, 2025 | $-162.40 | $-116.23 | -39.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 | $100.0K | |
| R&D Expense | $7M | $4M | $3M | $242.0K | $5M | $4M | |
| SG&A Expense | $5M | $4M | $8M | $2M | $4M | $1M | |
| Operating Expenses | $12M | $8M | $11M | $2M | $9M | $5M | |
| Operating Income | $-12M | $-8M | $-11M | $-2M | $-9M | $-5M | |
| Other Non-op | · | $0 | $250.0K | $0 | $61.0K | $0 | |
| Income Tax | $3.0K | $2.0K | · | · | · | · | |
| Net Income | $-12M | $-8M | $-13M | $-3M | $-9M | $-5M | |
| EPS (Basic) | $-121.80 | $-1545.55 | $-5018.09 | $-24.95 | $-1.42 | $-1.07 | |
| EPS (Diluted) | $-121.80 | $-1545.55 | $-5018.09 | $-24.95 | $-1.42 | $-1.07 | |
| Shares (Basic) | 98,162 | 6,547 | 2,598 | 128,994 | 6,541,097 | 4,506,216 | |
| Shares (Diluted) | 98,162 | 6,547 | 2,598 | 128,994 | 6,541,097 | 4,506,216 | |
| EBITDA | $-12M | $-8M | $-11M | $-7M | $-9M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $5M | $2M | $9.0K | $4M | $109.0K | |
| Prepaid Expense | $363.0K | $587.0K | $1M | $303.0K | $619.0K | $565.0K | |
| Current Assets | $9M | $6M | $3M | $312.0K | $8M | $674.0K | |
| PP&E (Net) | $3.0K | $4.0K | $8.0K | $4.0K | $0 | $2.0K | |
| PP&E (Gross) | $37.0K | $34.0K | $34.0K | $26.0K | · | · | |
| Accum. Depreciation | $34.0K | $30.0K | $26.0K | $22.0K | · | · | |
| Other Non-current Assets | · | · | · | $0 | $206.0K | $279.0K | |
| Total Assets | $9M | $6M | $3M | $383.0K | $8M | $955.0K | |
| Accounts Payable | $2M | $897.0K | $1M | $1M | $918.0K | $1M | |
| Accrued Liabilities | $750.0K | $691.0K | $1M | $36.0K | $1M | $847.0K | |
| Short-term Debt | · | · | $0 | $602.0K | $0 | $47.0K | |
| Current Liabilities | $3M | $2M | $3M | $2M | $2M | $2M | |
| Capital Leases | $15.0K | $71.0K | $0 | $14.0K | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $72.0K | $170.0K | |
| Total Liabilities | $3M | $2M | $3M | $2M | $3M | $2M | |
| Total Debt | · | · | $0 | · | $0 | · | |
| Paid-in Capital | · | · | · | · | · | $11M | |
| Retained Earnings | $-52M | $-40M | $-32M | $-18M | $-22M | $-13M | |
| AOCI | · | · | · | $0 | $-2.0K | $0 | |
| Stockholders' Equity | $6M | $4M | $259.0K | $-2M | $-5M | $-1M | |
| Liabilities + Equity | $9M | $6M | $3M | $383.0K | $8M | $955.0K | |
| Shares Outstanding | 497,693 | 18,768 | 104 | 646 | 121,631 | 4,506,216 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $793.0K | $148.0K | $388.0K | $25.0K | $626.0K | $154.0K | |
| Operating Cash Flow | $-10M | $-9M | $-9M | $-1M | $-8M | $-4M | |
| CapEx | $3.0K | $0 | $8.0K | $3.0K | $0 | $2.0K | |
| Investing Cash Flow | $-3.0K | $0 | $-8.0K | $-3.0K | $-4M | $-2.0K | |
| Stock Issued | · | · | $12M | $0 | · | · | |
| Net Stock Activity | · | · | $12M | · | · | · | |
| Financing Cash Flow | $13M | $12M | $11M | $1M | $16M | $-4.0K | |
| Net Change in Cash | $3M | $3M | $2M | $-81.0K | $4M | $-4M | |
| Free Cash Flow | $-10M | $-9M | $-9M | · | $-8M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -166.0% | -188.8% | -780.9% | -112.5% | -200.3% | · | |
| ROE | -256.3% | -213.4% | -1048.8% | 417.6% | -127.9% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.4 | 1.1 | 2.3 | 3.3 | · | |
| Quick Ratio | 3.1 | 3.1 | 0.7 | 2.1 | 1.5 | · | |
| Debt / Equity | · | · | 0.0 | · | 0.0 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.07 | $7.67 | $0.40 | $0.17 | $0.85 | · | |
| Revenue / Share | · | · | · | · | $0.00 | · | |
| Cash Flow / Share | $-103.77 | $-46.98 | $-19.48 | $-0.70 | $-1.27 | · | |
| Cash / Share | $16.53 | $9.57 | $2.80 | $0.28 | $0.54 | · | |
| EPS (TTM) | $-121.80 | $-1545.55 | $-5018.09 | $-24.95 | $-1.42 | $-1.07 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $100.0K | |
| Net Income TTM | $-12M | $-8M | $-13M | $-3M | $-9M | $-5M | |
| Market Cap | $122.9K | $7M | $385M | $181.46B | $1.89T | · | |
| Enterprise Value | · | · | $383M | · | $1.89T | · | |
| P/E | -0.0 | -0.0 | -0.1 | -539.4 | -195444.9 | · | |
| P/B | 0.0 | 1.8 | 1484.9 | 77479.7 | 324987.7 | · | |
| P / Tangible Book | 0.0 | 1.8 | 1484.9 | · | · | · | |
| P / Cash Flow | -0.0 | -0.9 | -42.8 | -25432.0 | -227475.8 | · | |
| P / FCF | -0.0 | -0.9 | -42.7 | · | -227475.8 | · | |
| EV / EBITDA | · | · | -33.6 | · | -204209.4 | · | |
| EV / FCF | · | · | -42.5 | · | -227475.3 | · | |
| Earnings Yield | -49311.7% | -10980.0% | -842.5% | -0.19% | 0.00% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $407.0K | $361.0K | $2M | $2M | $2M | $2M | $833.0K | $1M | $877.0K | $933.0K | $1M | $1M | $880.0K | $116.0K | $-1M | $63.0K | |
| SG&A Expense | $1M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $962.0K | $979.0K | $1M | $5M | $872.0K | $381.0K | $123.0K | |
| Operating Expenses | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $6M | $988.0K | $-770.0K | $186.0K | |
| Operating Income | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-6M | $-988.0K | $770.0K | $-186.0K | |
| Other Non-op | · | · | · | · | · | · | · | $0 | · | · | $0 | $250.0K | · | · | $0 | $0 | |
| Net Income | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-7M | $-2M | $-2M | $-351.0K | |
| EPS (Basic) | $-0.91 | $-1.61 | $-113.41 | $-1.28 | $-36.72 | $-162.30 | $-1371.23 | $-11.42 | $-61.85 | $-101.05 | $-4697.90 | $-65.78 | $-239.37 | $-15.04 | $-12.59 | $-0.39 | |
| EPS (Diluted) | $-0.91 | $-1.61 | $-113.41 | $-1.28 | $-36.72 | $-162.30 | $-1371.23 | $-11.42 | $-61.85 | $-101.05 | $-4697.90 | $-65.78 | $-239.37 | $-15.04 | $-12.59 | $-0.39 | |
| Shares (Basic) | 1,804,951 | 1,241,001 | · | 2,621,498 | 78,757 | 18,768 | · | 185,924 | 36,379 | 18,665 | · | 32,485 | 28,181 | 142,988 | · | 896,117 | |
| Shares (Diluted) | 1,804,951 | 1,241,001 | · | 2,621,498 | 78,757 | 18,768 | · | 185,924 | 36,379 | 18,665 | · | 32,485 | 28,181 | 142,988 | · | 896,117 | |
| EBITDA | $-2M | $-2M | · | $-3M | $-3M | $-3M | · | $-2M | $-2M | $-2M | · | $-2M | $-6M | $-2M | · | $-1M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $11M | $8M | $4M | $5M | $3M | $5M | $5M | $6M | $4M | $2M | $3M | $5M | $2M | $9.0K | $5M | |
| Prepaid Expense | $387.0K | $231.0K | $363.0K | $642.0K | $454.0K | $649.0K | $587.0K | $577.0K | $531.0K | $337.0K | $1M | $879.0K | $793.0K | $432.0K | $303.0K | $418.0K | |
| Current Assets | $11M | $11M | $9M | $5M | $6M | $4M | $6M | $5M | $7M | $4M | $3M | $4M | $6M | · | $312.0K | $6M | |
| PP&E (Net) | $2.0K | $2.0K | $3.0K | $1.0K | $2.0K | $3.0K | $4.0K | $5.0K | $6.0K | $7.0K | $8.0K | $9.0K | $9.0K | · | $4.0K | · | |
| PP&E (Gross) | $37.0K | $37.0K | $37.0K | $34.0K | $34.0K | $34.0K | $34.0K | $34.0K | $34.0K | $34.0K | $34.0K | $34.0K | $33.0K | · | $26.0K | · | |
| Accum. Depreciation | $35.0K | $35.0K | $34.0K | $33.0K | $32.0K | $31.0K | $30.0K | $29.0K | $28.0K | $27.0K | $26.0K | $25.0K | $24.0K | · | $22.0K | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Total Assets | $11M | $11M | $9M | $5M | $6M | $4M | $6M | $5M | $7M | $5M | $3M | $4M | $6M | $2M | $383.0K | $6M | |
| Accounts Payable | $526.0K | $303.0K | $2M | $1M | $1M | $1M | $897.0K | $1M | $1M | $637.0K | $1M | $988.0K | $307.0K | $528.0K | $1M | $1M | |
| Accrued Liabilities | $530.0K | $433.0K | $750.0K | $1M | $960.0K | $1M | $691.0K | $531.0K | $935.0K | $999.0K | $1M | $1M | $1M | $1M | $36.0K | $700.0K | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | $602.0K | · | |
| Current Liabilities | $1M | $794.0K | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | · | $2M | $2M | |
| Capital Leases | $0 | $0 | $15.0K | $30.0K | $44.0K | $58.0K | $71.0K | $84.0K | $96.0K | $109.0K | $0 | $0 | $0 | · | $14.0K | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Total Liabilities | $1M | $794.0K | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | |
| Retained Earnings | $-55M | $-54M | $-52M | $-49M | $-46M | $-43M | $-40M | $-38M | $-36M | $-33M | $-32M | $-30M | $-27M | $-31M | $-18M | $-27M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-1.0K | |
| Stockholders' Equity | $10M | $11M | $6M | $2M | $3M | $1M | $4M | $4M | $5M | $3M | $259.0K | $2M | $4M | $31.0K | $-2M | $3M | |
| Liabilities + Equity | $11M | $11M | $9M | $5M | $6M | $4M | $6M | $5M | $7M | $5M | $3M | $4M | $6M | $2M | $383.0K | $6M | |
| Shares Outstanding | 2,186,115 | 1,584,933 | 497,693 | 3,268,727 | 2,496,800 | 525,358 | 18,768 | 5,022,901 | 801,914 | 3,196,488 | 2,909 | 2,956,354 | 2,956,354 | 449,408 | 142,820 | 12,732,836 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $33.0K | $31.0K | $67.0K | $465.0K | $41.0K | $220.0K | $37.0K | $37.0K | $37.0K | $37.0K | $36.0K | $326.0K | $-59.0K | $13.0K | $25.0K | $-96.0K | |
| Operating Cash Flow | $-1M | $-4M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-6M | $-1M | $-3.0K | $-579.0K | $-844.0K | $4M | |
| CapEx | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | · | $3.0K | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $-8.0K | $0 | $-3.0K | $-2M | |
| Stock Issued | · | $7M | · | · | · | $0 | · | · | · | $6M | · | $-11M | $12M | $0 | $0 | $0 | |
| Net Stock Activity | · | $7M | · | · | · | · | · | · | · | $6M | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $7M | $7M | $1M | $5M | $-11.0K | $2M | $661.0K | $4M | $4M | $4M | $0 | $7M | $1M | $752.0K | $-3M | |
| Net Change in Cash | $-101.0K | $3M | $4M | $-1M | $2M | $-2M | $282.0K | $-2M | $2M | $2M | $-2M | $-1M | $7M | $451.0K | $-95.0K | $-2M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -14681.2% | · | -70200.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -14975.0% | · | -51650.0% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -14681.2% | · | -70200.0% | |
| ROA | -19.3% | -26.0% | · | -65.6% | -45.5% | -70.6% | · | -43.0% | -35.5% | -56.5% | · | -42.9% | -98.9% | -59.6% | · | -13.2% | |
| ROE | -24.2% | -34.0% | · | -118.8% | -71.9% | -152.2% | · | -72.1% | -51.4% | -133.4% | · | -75.2% | -175.1% | -141.3% | · | -17.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 14.2 | · | 1.7 | 2.4 | 1.4 | · | 3.1 | 3.1 | 2.6 | · | 2.0 | 3.5 | · | · | 2.6 | |
| Quick Ratio | 10.0 | 13.9 | · | 1.5 | 2.2 | 1.2 | · | 2.8 | 2.9 | 2.4 | · | 1.6 | 3.0 | · | · | 2.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.70 | $6.65 | · | $0.61 | $1.33 | $2.29 | · | $0.73 | $5.88 | $0.88 | · | $0.75 | $1.37 | $0.07 | · | $0.27 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.04 | · | $0.00 | |
| Cash Flow / Share | · | $-2.97 | · | · | · | $-3.30 | · | · | · | $-0.53 | · | · | · | $-4.71 | · | · | |
| Cash / Share | $5.01 | $6.97 | · | $1.24 | $2.05 | $6.25 | · | $0.94 | $7.92 | $1.28 | · | $1.18 | $1.62 | $3.70 | · | $0.37 | |
| EPS (TTM) | $-117.21 | $-153.02 | · | $-1571.53 | $-1581.67 | $-1606.80 | · | $-4872.22 | $-4926.58 | $-5104.10 | · | $-332.78 | $-267.39 | $-28.37 | · | $-12.80 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-10M | $-11M | · | $-11M | $-10M | $-9M | · | $-8M | $-8M | $-13M | · | $-13M | $-12M | $-5M | · | $-4M | |
| Market Cap | $4M | $4M | · | $7M | $3M | $2M | · | $31M | $26M | $537M | · | $7.09B | $19.44B | $7.55B | · | $168.42B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $7.09B | $19.43B | · | · | · | |
| P/E | -0.0 | -0.0 | · | -0.0 | -0.0 | -0.1 | · | -0.0 | -0.2 | -0.9 | · | -201.8 | -688.5 | -16581.3 | · | -28933.7 | |
| P/B | 0.4 | 0.3 | · | 3.4 | 1.0 | 1.4 | · | 8.4 | 5.5 | 191.9 | · | 3183.2 | 4813.6 | 243556.2 | · | 48689.0 | |
| P / Tangible Book | 0.4 | 0.3 | · | 3.4 | 1.0 | 1.4 | · | 8.4 | 5.5 | 191.9 | · | 3183.2 | 4813.6 | 243556.2 | · | 48689.0 | |
| P / Cash Flow | · | -1.0 | · | · | · | -1.0 | · | · | · | -243.7 | · | · | · | -3568.2 | · | · | |
| Earnings Yield | -6622.0% | -6682.1% | · | -2724.6% | -4378.9% | -1793.3% | · | -2835.4% | -539.1% | -108.5% | · | -0.50% | -0.15% | -0.01% | · | 0.00% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 |
| Net Income | $-12M | $-8M | $-13M | $-3M | $-9M |
| Diluted EPS | $-121.80 | $-1545.55 | $-5018.09 | $-24.95 | $-1.42 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | · | 0.0 | · | 0.0 |
| Current Ratio | 3.3 | 3.4 | 1.1 | 2.3 | 3.3 |
| Quick Ratio | 3.1 | 3.1 | 0.7 | 2.1 | 1.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-10M | $-9M | $-9M | · | $-8M |
Institutional owners (13F) 12 filers · $119K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
12
Value held
$119K
New positions
6
Exited positions
1
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 6 (+1 vs prior Q) | 1 (-1 vs prior Q) | 1 (+1 vs prior Q) | 2 (+1 vs prior Q) | +65K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $37,821 | 21,368 | 31.80% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $24,547 | 13,869 | 20.64% | Shares |
| CITADEL ADVISORS LLC | $23,676 | 13,376 | 19.91% | Shares |
| MORGAN STANLEY | $15,464 | 8,737 | 13.00% | Shares |
| UBS Group AG | $8,708 | 4,920 | 7.32% | Shares |
| Tower Research Capital LLC (TRC) | $4,308 | 2,434 | 3.62% | Shares |
| VANGUARD GROUP INC | $4,199 | 17,000 | 3.53% | Shares |
| BARCLAYS PLC | $147 | 83 | 0.12% | Shares |
| HRT FINANCIAL LP | $50 | 28,784 | 0.04% | Shares |
| BlackRock, Inc. | $12 | 7 | 0.01% | Shares |
| Caitong International Asset Management Co., Ltd | $4 | 2 | 0.00% | Shares |
| DANSKE BANK A/S | $4 | 2 | 0.00% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Albert Agro | April 25, 2023 | · | Initial filing | · | SEC |
| W. Marc Hertz | April 25, 2023 | · | Initial filing | · | SEC |
| Vipin Kumar Chaturvedi | April 25, 2023 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | March 16, 2021 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | Feb. 16, 2021 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 15 insiders · 4 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Walter Marc Hertz | Chief Executive Officer | Sept. 18, 2025 A | 385,510 | 0 | 0 | $0 |
| Vipin Chaturvedi | Chief Scientific Officer | Sept. 18, 2025 A | 172,189 | 0 | 0 | $0 |
| Albert Agro | Chief Medical Officer | April 21, 2023 A | 172,189 | 0 | 0 | $0 |
| Penny Toren | SVP, Regul Affairs & Prog Mgmt | May 14, 2021 A | · | 0 | 0 | $0 |
| David Charles Baker | Director | Sept. 18, 2025 A | 8,843 | 0 | 0 | $0 |
| Camilla V Simpson | Director | Sept. 18, 2025 A | · | 0 | 0 | $0 |
| Roelof Rongen | Director | Sept. 18, 2025 A | · | 0 | 0 | $0 |
| David Leslie Szekeres | Director | Sept. 18, 2025 A | · | 0 | 0 | $0 |
| Marella Thorell | Director | Dec. 13, 2022 J | 9,506 | 0 | 0 | $0 |
| Richard Ammer | Director | June 9, 2022 A | 47,063 | 0 | 0 | $0 |
| Joseph E Payne | Director | June 9, 2022 A | 17,500 | 0 | 0 | $0 |
| Meenu Chhabra | Director | Feb. 23, 2022 A | · | 0 | 0 | $0 |
| Ofir Levi | Director | May 14, 2021 A | · | 0 | 0 | $0 |
| SALMON Pharma GmbH | 10% owner | Feb. 12, 2021 J | 47,063 | 0 | 0 | $0 |
| Leanne M. Kelly | · | Sept. 18, 2025 A | 6,250 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 21 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| EWUS · iShares Trust | 0.33% | 60,908 SH | Sept. 11, 2026 | Daily |
| IFGL · iShares Trust | 0.24% | 84,230 SH | Sept. 11, 2026 | Daily |
| VNQI · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.16% | 2,671,092 SH | Aug. 19, 2026 | Daily |
| ERET · iShares Trust | 0.10% | 6,054 SH | Sept. 11, 2026 | Daily |
| IEUS · iShares Trust | 0.09% | 74,525 SH | Sept. 11, 2026 | Daily |
| REET · iShares Trust | 0.09% | 1,990,566 SH | Sept. 11, 2026 | Daily |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.07% | 113,881 | Oct. 2, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.04% | 2,815,354 SH | Aug. 19, 2026 | Daily |
| SCZ · iShares Trust | 0.04% | 2,312,633 SH | Sept. 11, 2026 | Daily |
| ISCF · iShares Trust | 0.02% | 49,188 SH | Sept. 10, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 42,362 SH | Sept. 11, 2026 | Daily |
| IEUR · iShares Trust | 0.01% | 438,002 SH | Sept. 11, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 1,770,712 SH | Aug. 19, 2026 | Daily |
| IEFA · iShares Trust | 0.01% | 5,095,631 SH | Sept. 11, 2026 | Daily |
| IDEV · iShares Trust | 0.01% | 733,449 SH | Sept. 10, 2026 | Daily |
| IXUS · iShares Trust | 0.00% | 976,245 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 21,368 SH | Aug. 19, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 10,462,814 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 513,501 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 7,062,627 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.00% | 147,992 SH | Aug. 19, 2026 | Daily |
GRI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 6 analysts
BUY
Median target
$18.50
+843.9%
1 16.7%
Strong Buy
4 66.7%
Buy
1 16.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-30Mean target $18.50 +843.9%
← Below all targets
Current price $1.96
Low$10.00
Mean$18.50
High$27.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026